UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Reprogramming the antigen specificity of B cells using genome-editing technologies

Voss, JE; Gonzalez-Martin, A; Andrabi, R; Fuller, RP; Murrell, B; McCoy, LE; Porter, K; ... Burton, DR; + view all (2019) Reprogramming the antigen specificity of B cells using genome-editing technologies. Elife , 8 , Article e42995. 10.7554/eLife.42995. Green open access

[thumbnail of Voss et al elife-42995.pdf]
Preview
Text
Voss et al elife-42995.pdf - Published Version

Download (4MB) | Preview

Abstract

We have developed a method to introduce novel paratopes into the human antibody repertoire by modifying the immunoglobulin (Ig) genes of mature B cells directly using genome editing technologies. We used CRISPR-Cas9 in a homology directed repair strategy, to replace the heavy chain (HC) variable region in B cell lines with that from an HIV broadly neutralizing antibody (bnAb), PG9. Our strategy is designed to function in cells that have undergone VDJ recombination using any combination of variable (V), diversity (D) and joining (J) genes. The modified locus expresses PG9 HC which pairs with native light chains (LCs) resulting in the cell surface expression of HIV specific B cell receptors (BCRs). Endogenous activation-induced cytidine deaminase (AID) in engineered cells allowed for Ig class switching and generated BCR variants with improved HIV neutralizing activity. Thus, BCRs engineered in this way retain the genetic flexibility normally required for affinity maturation during adaptive immune responses. Peripheral blood derived primary B cells from three different donors were edited using this strategy. Engineered cells could bind the PG9 epitope and sequenced mRNA showed PG9 HC transcribed as several different isotypes after culture with CD40 ligand and IL-4.

Type: Article
Title: Reprogramming the antigen specificity of B cells using genome-editing technologies
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.7554/eLife.42995
Publisher version: https://doi.org/10.7554/eLife.42995
Language: English
Additional information: © 2019, Voss et al. This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.
Keywords: B cell, CAR-B, HIV, bnAb, engineering, human, immunology, infectious disease, inflammation, microbiology, vaccine
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity
URI: https://discovery.ucl.ac.uk/id/eprint/10067346
Downloads since deposit
124Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item